HomeCYTO • NASDAQ
add
Altamira Therapeutics Ltd
Previous close
$1.62
Day range
$1.60 - $1.66
Year range
$1.35 - $28.40
Market cap
3.67M USD
Avg Volume
2.34M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(CHF) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | — | — |
Net income | — | — |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CHF) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 617.41K | 3,910.45% |
Total assets | 7.69M | 22.08% |
Total liabilities | 1.24M | -91.55% |
Total equity | 6.46M | — |
Shares outstanding | 2.24M | — |
Price to book | 0.37 | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
(CHF) | Dec 2023info | Y/Y change |
---|---|---|
Net income | — | — |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2003
Headquarters
Website
Employees
10